Last month, the hospital operator announced its intent to explore a number of possible deals with private equity sponsors and other financial alternatives after disclosing the company’s growing financial troubles.
CHS CEO Wayne Smith said the stockholders’ rights agreement is in place for the next six months to prevent someone from buying a potentially controlling block of the company before it can fully review other options.
Billionaire Tianqiao Chen recently increased his holdings in the company, maintaining a 13.8 percent stake in CHS.
Mr. Smith notes that the agreement is not intended to and won’t prevent a transaction involving the regular buying and selling of company stock in the marketplace.
More articles on transactions and valuations:
UMass Memorial merger set to close in next six months
Judge OKs Coshocton hospital sale
Winthrop, NYU Langone sign affiliation agreement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
